COMPARISON OF BIOAVAILABILITIES AND DISSOLUTION CHARACTERISTICS OF COMMERCIAL TABLET FORMULATIONS OF SULFAMETHIZOLE

被引：15
|
作者：
MATTOK, GL
MCGILVERAY, IJ
机构：
来源：
JOURNAL OF PHARMACEUTICAL SCIENCES | 1972年 / 61卷 / 05期
关键词：
D O I：
10.1002/jps.2600610515
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：746 / +
页数：1
相关论文
共 50 条
  • [31] Influence of Storage Conditions on the Pantoprazole Dissolution Profile for Gastro-Resistant Tablet Formulations
    Panic, Jelena Canji
    Todorovic, Nemanja
    Jonas, Kristina
    Stjepanovic, Ana
    Svonja-Parezanovic, Gordana
    Vukovic, Milana
    Lalic-Popovic, Mladena
    DISSOLUTION TECHNOLOGIES, 2023, 30 (02): : GC1 - GC11
  • [32] In Vivo Relevance of a Biphasic In Vitro Dissolution Test for the Immediate Release Tablet Formulations of Lamotrigine
    Incecayir, Tuba
    Demir, Muhammed Enes
    PHARMACEUTICS, 2023, 15 (10)
  • [33] Pharmacokinetic comparison of two 4 mg tablet formulations of tizanidine
    Al-Ghazawi, Mutasim
    Alzoubi, Mamoun
    Faidi, Bashar
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (03) : 255 - 262
  • [34] Correlating viscosity and in vitro dissolution to in vivo pharmacokinetic profiles of proprietary injected-molded tablet formulations with abuse-deterrent characteristics
    Elhauge, Torben
    Skak, Nikolaj
    Overgard, Martin Jan
    Lindhardt, Karsten
    DRUG AND ALCOHOL DEPENDENCE, 2017, 171 : E58 - E58
  • [35] In Vitro Dissolution Profiles of Two Diltiazem Tablet Formulations and a Compounded Capsule Formulation: A Comparative Study
    Castro e Souza, Mateus Araujo
    de Oliveira Pereira, Carlos Eduardo
    Andrade Nogueira, Fernando Henrique
    Pianetti, Gerson Antonio
    DISSOLUTION TECHNOLOGIES, 2017, 24 (02): : 38 - 42
  • [36] Predictive possibilities of in vitro dissolution testing for clinical bioequivalence studies of oral tablet sulpiride formulations
    Kopecky, J.
    Svoboda, Z.
    Kubant, P.
    Petr, P.
    Chladek, J.
    Pastera, J.
    Zoulova, J.
    Kvetina, J.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 225 - 225
  • [37] Scale-up effects on dissolution and bioavailability of propranolol hydrochloride and metoprolol tartrate tablet formulations
    Natalie D. Eddington
    Guvinder Singh Rekhi
    Larry J. Lesko
    Larry L. Augsburger
    AAPS PharmSciTech, 1 (2)
  • [38] HPLC determination of olanzapine and carbamazepine in their nicotinamide cocrystals and investigation of the dissolution profiles of cocrystal tablet formulations
    Renkoglu, Pelin
    Celebier, Mustafa
    Arica-Yegin, Betul
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2015, 20 (03) : 380 - 384
  • [39] Fluctuation in therapeutic control associated with interchange of prednisolone tablet formulations: Assessment of bioequivalence by dissolution test
    Konishi, H
    Kanemoto, K
    Ikuno, Y
    Minouchi, T
    Inoue, T
    Hodohara, K
    Fujiyama, Y
    Yamaji, A
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2002, 122 (10): : 813 - 817
  • [40] COMPARISON OF THE RELATIVE BIOAVAILABILITY AND PHARMACOKINETICS OF CARBAMAZEPINE TABLETS AND CHEWABLE TABLET FORMULATIONS
    MAAS, B
    GARNETT, WR
    COMSTOCK, TJ
    PELLOCK, JM
    ANNALS OF NEUROLOGY, 1985, 18 (03) : 379 - 379
12345